Objective Using a population-based registry, we evaluated the impact of neoadjuvant
radiotherapy and lymphadenectomy on survival of patients undergoing curative-intent …

Objective: To compare overall survival in patients with esophageal adenocarcinoma who
underwent transhiatal esophagectomy (THE) with limited lymphadenectomy or transthoracic …

For locally advanced esophageal and gastroesophageal (GE) junction adenocarcinoma,
surgery remains the mainstay of treatment. Various reviews have reported 5-year overall …

Importance While neoadjuvant chemoradiation for esophageal cancer improves oncologic
outcomes for a broad group of patients with locally advanced and/or node-positive tumors, it …

Objective: We sought to determine the extent of lymphadenectomy that optimizes staging
and survival in patients with locally advanced EAC treated with neoadjuvant …

Background In the UK, it is standard practice to treat esophageal adenocarcinoma with
neoadjuvant chemotherapy (no radiation) and surgery. We examined the prognostic value of …

Objective To determine the association between neoadjuvant chemotherapy and
chemoradiation therapy on completeness of pathologic response and to assess the impact …

AIM: To investigate the role of neoadjuvant chemoradiotherapy in prognosis and surgery for
esophageal carcinoma by a meta-analysis. METHODS: PubMed and manual searches were …

Background Neoadjuvant treatment is standard for locally advanced esophageal cancer.
However, whether the addition of radiation to neoadjuvant regimen improves survival …

Background The prognostic value of lymph node regression (LNR) following neoadjuvant
chemotherapy (nCT) for oesophageal and gastro-oeosphageal adenocarcinoma remains …